Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Anetumab Ravtansine in Treating Patients with Mesothelin Positive, Locally Advanced, or Metastatic Pancreatic Cancer That Cannot Be Removed by Surgery

Pancreatic

This phase II trial studies how well anetumab ravtansine works in treating patients with mesothelin positive pancreatic cancer that has spread to other places in the body and cannot be removed by surgery. Monoclonal antibodies, such as anetumab ravtansine, may find tumor cells and help kill them.
Pancreatic
II
Cardin, Dana
NCT03023722
VICCGI1720

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: